DEVICE: Liofilchem Mic Test Strip (MTS) (08055182873043)
Device Identifier (DI) Information
Liofilchem Mic Test Strip (MTS)
Tetracycline TE 0.016-256 µg/ml, 1 strip
In Commercial Distribution
$92114-1
LIOFILCHEM SRL
Tetracycline TE 0.016-256 µg/ml, 1 strip
In Commercial Distribution
$92114-1
LIOFILCHEM SRL
The MTS™ Tetracycline 0.016-256 μg/mL is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of bacteria. MTS™ consists of specialized paper impregnated with a pre-defined concentration gradient of an antimicrobial agent, which is used to determine the minimum inhibitory concentration (MIC) in μg/mL of antimicrobial agents against bacteria as tested on agar media using overnight incubation and manual reading procedures. The MTS™ Tetracycline at concentrations of 0.016-256 μg/mL should be interpreted at 16-20 hours of incubation.
Tetracycline has been shown to be active both clinically and in vitro against these bacterial species according to the FDA drug approved label:
Staphylococcus aureus
Acinetobacter baumannii
Escherichia coli
Klebsiella aerogenes
Klebsiella oxytoca
Klebsiella pneumoniae
Device Characteristics
Labeling does not contain MRI Safety Information | |
No | |
No | |
Yes | |
No | |
No | |
No | |
No | |
No |
GMDN
[?]GMDN© Term Code, Names and Definitions (*Terms of Use): GMDN® is a registered trademark of The GMDN Agency. All rights reserved. Used under licence from The GMDN Agency Ltd.
GMDN Term Code | GMDN Term Name | GMDN Term Definition | GMDN Term Status [?] | Implantable? |
---|---|---|---|---|
37300 | Multiple antibacterial minimum inhibitory concentration (MIC) IVD, kit |
A collection of reagents or test strips, and other associated materials, containing multiple antibacterial/antibiotic agents (i.e., a drug intended for treatment and/or prevention of a bacterial infection, excluding mycobacterial infection) at specified concentration gradients, intended to be used to determine the degree of susceptibility or the minimum inhibitory concentration (MIC) of a range of antibacterials against a specific bacterial microorganism, isolated from a clinical specimen by culture.
|
Active | false |
FDA Product Code
[?]Product Code | Product Code Name |
---|---|
JWY | Manual Antimicrobial Susceptibility Test Systems |
FDA Premarket Submission
FDA Premarket Submission Number [?] | Supplement Number [?] |
---|---|
K183140 | 000 |
Sterilization
Storage and Handling
[?]Storage and Handling |
---|
Storage Environment Temperature: between -20 and 8 Degrees Celsius |
Clinically Relevant Size
[?]Size Type Text |
---|
No Device Sizes |
Device Record Status
aca7f99e-2cd1-4824-9ecc-193f72ab4b51
March 12, 2019
1
March 04, 2019
March 12, 2019
1
March 04, 2019
Alternative and Additional Identifiers Additional Identifiers
Package DI
[?]Package DI Number | Quantity per Package | Contains DI Package | Package Discontinue Date | Package Status | Package Type |
---|---|---|---|---|---|
28055182873047 | 30 | 08055182873043 | In Commercial Distribution | box | |
18055182873040 | 10 | 08055182873043 | In Commercial Distribution | box |
Secondary DI
[?]Issuing Agency [?] | Secondary DI Number |
---|---|
No Secondary DIs found |
Unit of Use DI
[?]
Unit of Use DI Number:
No Unit of Use DI Numbers Found
CLOSE
Direct Marking (DM)
[?]Production Identifier(s) in UDI
[?]Customer Contact
[?]
No Customer Contact currently defined